13F Holdings
中文EN

NTRB NutriBand Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1676047 · Fiscal year ends 01/31

Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-37.3%
TTM net income YoY32.2%
TTM EPS YoY83.0%
Revenue 3-yr CAGR-10.8%
Net income 3-yr CAGR—

Margins

Gross margin33.1%
Operating margin-435.6%
Net margin-430.4%
FCF margin—
EBITDA margin-426.5%

Returns

ROE-100.7%
ROA-84.6%
ROIC (approx.)-326.9%
Asset turnover0.20x

Leverage & solvency

Liabilities / assets15.3%
Debt / equity0.00x
Current ratio4.21x
Interest coverage-339.35x

Cash quality & payout

Operating cash flow / net income0.52x
Accruals ratio-40.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-01-31FY20252025-01-31FY20242024-01-31FY20232023-01-31FY20222022-01-31
Income statement
Revenue$2.04M$2.14M$2.09M$2.08M$1.42M
Cost of revenue$1.47M$1.40M$1.22M$1.33M$917,844
Gross profit$566,308$743,317$862,105$750,404$554,310
R&D expense$1.89M$3.12M$1.96M$982,227$411,383
SG&A expense$6.99M$4.31M$3.77M$3.92M$4.02M
Operating income-$8.32M-$10.28M-$4.87M-$4.48M-$6.11M
Interest expense$22,535$21,407$75,815$8,289$118,421
Pretax income-$8.23M-$10.48M-$5.49M-$4.48M-$6.18M
Net income-$8.23M-$10.48M-$5.49M-$4.48M-$6.18M
EBITDA-$8.12M-$10.00M-$4.58M-$4.15M-$5.80M
EPS (basic)-2.58-0.99-0.69-0.53-0.80
EPS (diluted)-2.58-0.99-0.69-0.53-0.80
Weighted avg. shares (diluted)11.64M10.61M7.95M8.46M7.93M
Banking
Loans, net————$121,544
Deposits———$250,000$250,000
Balance sheet
Cash & equivalents$4.57M$4.31M$118,675$1.99M$4.89M
Receivables$118,404$73,847$148,649$113,045$71,380
Inventory$117,987$212,041$168,605$229,335$131,648
Current assets$4.99M$4.79M$1.02M$2.69M$5.47M
PP&E, net$567,255$695,063$774,924$897,735$979,297
Goodwill$1.72M$1.72M$5.02M$5.02M$5.35M
Intangibles$200,427$261,092$667,280$780,430$926,913
Total assets$7.55M$7.47M$7.52M$9.46M$12.74M
Current liabilities$784,281$982,845$999,093$748,613$779,256
Short-term debt——$2.00M——
Total liabilities$868,447$1.04M$1.08M$883,387$880,375
Shareholders' equity$6.68M$6.43M$6.44M$8.57M$11.86M
Shares outstanding12.16M11.07M8.86M7.83M9.15M
Cash flow statement
Operating cash flow-$5.13M-$4.63M-$3.53M-$2.99M-$2.81M
Capital expenditure$5,324$92,043$51,761$79,304$81,595
Free cash flow-$5.14M-$4.72M-$3.58M-$3.07M-$2.89M
Investing cash flow-$5,324-$92,043-$51,761-$79,304-$81,595
Financing cash flow$5.40M$8.54M$2.09M$160,074$7.63M
Depreciation & amortization$193,797$285,054$287,722$330,143$308,741
Stock-based compensation$2.63M$1.41M$499,856$732,130$365,000

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.